Photo via BBC News

From Amazon retreats to clinical research: The rise of psychedelic therapy

Read the original at BBC News ↗
Cite

Howe, C. (2026, September 29). From Amazon retreats to clinical research: The rise of psychedelic therapy. BBC News. https://www.bbc.co.uk/news/articles/cmvgy9ew7815o?at_medium=RSS&at_campaign=rss

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

BBC News · collected 2026-09-29 · by Collette Howe

Quick Summary

Psychedelic therapy is gaining attention as a potential treatment for depression, moving from retreats in the Amazon to clinical research at Newcastle's CaPE Clinic. Claire Torpey, who tried conventional therapies without success, found transformative benefits through legal psychedelic experiences abroad involving psilocybin and ayahuasca. At the clinic, researchers are studying whether psilocybin can help patients by disrupting established thought patterns under controlled conditions, with sessions including extensive preparation and support from experts like Dr Mourad Wahba and clinical psychologist Tom Sharp.
Written by AI on 2026-09-29, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

Claire Torpey from Tynemouth, North Tyneside, UK, turned to psychedelic retreats after traditional therapies like counselling failed to alleviate her deep sadness and anxiety. She attended retreats in South and Central America where she legally took psilocybin and ayahuasca as part of guided therapeutic programs. In the UK, psilocybin and DMT, a compound found in ayahuasca, are classified as Class A drugs under Schedule 1, indicating they have no recognized medicinal use. Despite this classification, Claire believes these substances could offer significant mental health benefits that traditional treatments do not provide. With growing interest globally, researchers at the NHS and universities like Newcastle are starting to explore psychedelic therapy for conditions such as depression, questioning whether hallucinogenic drugs might become part of mainstream medical care in the future.

Written for “Psychedelic Therapy Growth” on 2026-11-02, grounded in this article and the 0 other(s) covering the same event.

Story

📰 Psychedelic Therapy Growth
Health · 1 article(s) covering the same event.

Compared with similar articles

This article reads unscored and hedges 17% of its claims. Each row says how that neighbour differs.
New York Post
Hedges 1 of 78 claims Outlet record 66/100
“The articles describe different instances of psychedelic therapy; one focuses on a participant's experience in Newcastle, UK, while the other discusses treatments for CEOs and celebrities in Mexico.”
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
60
sentences that state something as happening or true
Uncertain
17%
10 of 60 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
68/100
BBC News's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-29 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

BBC News · 4864 article(s) · 6 correction(s) detected
Running correction rate · 6 correction(s)

Who wrote this

Collette Howe
1 article(s) here · 1 carrying a prediction
🔮 Could hallucinogenic drugs one day become part of mainstream NHS care?
The only article under this byline in the corpus.

Topics

Amazonian NHS Newcastle North Tyneside Tynemouth

Subjects

Claire PERSON · 3× Newcastle GPE · 2× Amazonian NORP · 1× Care Pathway Enhancement (CaPE) Clinic ORG · 1× Claire Torpey PERSON · 1× Cumbria GPE · 1× NHS ORG · 1× North Tyneside GPE · 1× Northumberland GPE · 1× Tynemouth GPE · 1×

Narrative

"I don't believe that normal talk therapies would have got me there." 'Does not turn off depression' In the UK, psilocybin and DMT are Class A drugs and are classified as Schedule 1 substances, meaning they are considered to have no recognised medicinal use.
framing: assertive · carried by 1 article(s) · first seen 2026-09-29
🔮 Could hallucinogenic drugs one day become part of mainstream NHS care?

Claims (60 extracted, 10 hedged)

- Published From retreats in the Amazon to clinical trials in Newcastle, psychedelic therapy is attracting growing attention as a possible treatment for depression. asserted
therapy → publish → depression
Could hallucinogenic drugs one day become part of mainstream NHS care? uncertain
drugs → become → care
Claire Torpey had tried traditional forms of mental health support, including counselling. asserted
Torpey → try → counselling
But she says there was still something she could not shake. uncertain
she → say → ?
I was living in chronic anxiety," she says. asserted
she → live → anxiety
Claire, from Tynemouth, North Tyneside, spent part of her childhood in care and says the challenges she faced growing up were compounded by the deaths of her father and grandmother in consecutive years. asserted
she → spend → years
"There wasn't anything that was really moving the needle from my internal state. asserted
that → be → state
I was deeply sad and I didn't want to be here." asserted
I → want → ?
Seeking alternatives, Claire travelled to South and Central America to attend retreats where participants legally take psychedelics as part of guided therapeutic programmes. asserted
participants → seek → programmes
The retreats involved psilocybin, the psychoactive compound found in magic mushrooms, and ayahuasca, a traditional Amazonian brew containing the psychedelic compound DMT. asserted
retreats → involve → compound
Psychedelic tourism has grown in popularity, but experts warn that unethical and unregulated practices can pose serious risks. asserted
practices → grow → risks
There have been reports of participants dying after attending retreats and ceremonies abroad. asserted
participants → die → retreats
For Claire, however, she says the experience was transformative. asserted
experience → say → Claire
"It wasn't until I started taking these medicines that it started to lift," she says. "I started to find a place of peace and happiness. asserted
I → start → peace
It took me on a journey of forgiveness. asserted
It → take → forgiveness
"I don't believe that normal talk therapies would have got me there." 'Does not turn off depression' In the UK, psilocybin and DMT are Class A drugs and are classified as Schedule 1 substances, meaning they are considered to have no recognised medicinal use. asserted
they → believe → use
Yet interest in psychedelic-assisted therapy is growing. asserted
interest → assist → therapy
At Newcastle's Care Pathway Enhancement (CaPE) Clinic, run by Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, researchers are investigating whether psilocybin could help treat conditions including depression. uncertain
psilocybin → run → depression
The theory is that, when used in a controlled setting, psychedelics can help people process difficult thoughts and emotions. asserted
people → use → thoughts
Some researchers liken the mind to a snow globe: the drugs temporarily disrupt established thought patterns, allowing thoughts and feelings to settle differently and providing new perspectives on past experiences. asserted
thoughts → liken → experiences
Consultant psychiatrist Dr Mourad Wahba, who leads the research, says participants often report significant shifts in how they view themselves and their experiences. asserted
they → lead → themselves
"The idea is that through having this experience, people can change their behaviours and patterns of thinking," he says. asserted
he → have → thinking
The treatment involves extensive preparation and support before and after dosing sessions. asserted
treatment → involve → sessions
Clinical psychologist Tom Sharp helps facilitate the trials. asserted
Sharp → facilitate → trials
Participants receive psilocybin in capsule form before spending up to eight hours in a specially designed dosing room under the supervision of therapists. asserted
Participants → receive → therapists
"People can develop a sense of what might have caused their depression," he says. uncertain
he → develop → depression
Researchers are keen to temper expectations. asserted
Researchers → temper → expectations
"This type of work isn't some silver bullet," says Sharp. asserted
Sharp → say → work
"It doesn't turn off depression." asserted
It → turn → depression
Wahba agrees. asserted
Wahba → agree → ?
While early findings are encouraging, he says larger studies are still needed to establish how effective the treatments are and whether any benefits can be sustained in the longer term. asserted
benefits → say → term
The Royal College of Psychiatrists has backed further research into psychedelic-assisted therapy. asserted
College → back → therapy
Dr David Cousins, chair of its psychopharmacology committee, said: "The College supports further research into psychedelics such as psilocybin, which have the potential to help in the treatment of people with conditions such as depression, including those who are less responsive to other forms of care." Some researchers believe psychedelic-assisted therapy may offer longer-lasting benefits for certain patients by helping them address underlying thoughts, emotions and behaviours rather than simply managing symptoms. uncertain
them → say → symptoms
However, Cousins cautioned against seeking treatment outside regulated settings. asserted
Cousins → caution → settings
"We strongly advise against people self-medicating or seeking access to unregulated treatments as there are risks in doing so." asserted
people → advise → treatments
Supporters stress that psychedelic therapy is very different from recreational drug use. asserted
therapy → stress → use
In clinical settings, participants are screened, monitored and supported before, during and after treatment. asserted
participants → screen → treatment
'I became quite desperate' asserted
I → become → ?
Some UK charities and organisations are also helping people access psychedelic therapy overseas. asserted
people → help → therapy
Keith John Abraham, founder of Heroic Hearts Project UK, helps former military personnel attend retreats involving ayahuasca to support conditions such as post-traumatic stress disorder. asserted
personnel → help → disorder
…and 20 more, not listed.
💬Give feedback
🕘History 🎫Support